Cargando…
Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications
Such testing and trying time probably never seen before in the human history. The novel coronavirus disease abbreviated as COVID-19 is the ongoing health crisis which entered into human life in late December 2019. The ease of transmission between humans and the undetectability in early stage makes C...
Autores principales: | Hirawat, Rishabh, Saifi, Mohd Aslam, Godugu, Chandraiah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831473/ https://www.ncbi.nlm.nih.gov/pubmed/33358906 http://dx.doi.org/10.1016/j.lfs.2020.118923 |
Ejemplares similares
-
Lung fibrosis: Post-COVID-19 complications and evidences
por: Hirawat, Rishabh, et al.
Publicado: (2023) -
COVID-19 and fibrosis: Mechanisms, clinical relevance, and future perspectives
por: Saifi, Mohd Aslam, et al.
Publicado: (2022) -
Inhibition of discoidin domain receptors by imatinib prevented pancreatic fibrosis demonstrated in experimental chronic pancreatitis model
por: Bansod, Sapana, et al.
Publicado: (2021) -
An Adaptogen: Withaferin A Ameliorates in Vitro and in Vivo Pulmonary Fibrosis by Modulating the Interplay of Fibrotic, Matricelluar Proteins, and Cytokines
por: Bale, Swarna, et al.
Publicado: (2018) -
COVID-19 cytokine storm: targeting the appropriate cytokine
por: Cron, Randy Q
Publicado: (2021)